Svenska
Svenska
About us
About us
AlzeCure Pharma in brief
Mission, vision & strategy
A word from the CEO
Organization
Management team
Board of directors
Founders
Scientific advisors
Collaborations and Partnership
History
Career
Open positions
Research & development
Research & development
Project portfolio
NeuroRestore
Alzstatin
Alzheimer’s disease
Painless
ACD440
TrkA-NAM
Pain
Small molecules
Publications
Governance
Governance
Corporate Governance Reports
General meeting
General meetings
Nomination Committee
Board of directors
Management team
Remuneration
Auditors
Articles of association
Investors
Investors
Capital Markets Day 2023
AlzeCure Pharma on First North Premier Growth Market
Certified Adviser
Prospectuses
Rights Issue December 2022
Rights Issue 2022
Listing prospectus 2018
The share
Trading information
Sharecapital development
Dividend policy
Ownership structure
Insiders
Analyst Coverage
Financial reports
Financial calendar
Presentations and Interviews
Subscribe
Contact
Media
Media
Press releases
Presentations and Interviews
Video gallery
Image bank
Board of directors
Management
Founders
Logotype
Financial calendar
Subscribe
Contact
Contact
Contact
Office
Investors
Media
Search for:
Search
Media
Press releases
AlzeCure presents at DNB Nordic-American Healthcare Conference in New York December 6-7
November 28, 2023
AlzeCure presents at Stora Aktiedagarna on November 27
November 22, 2023
AlzeCure publishes its interim report for January – September 2023
November 9, 2023
All press releases
Calendar
Interim report Q4, October–December 2023
February 27, 2024
Annual report 2023
April 4, 2024
Interim report Q1, January-March 2024
May 2, 2024
All events
